A mutation found in TNPO2 (transportin 2) on Chromosome 19 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated?
Pathogenic; Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies